Whistleblower Law Insights

The story of a stock trader who went undercover to help the FBI expose a Ponzi scheme shows some of the problems that have confronted the government even when it knows that a fraud is occurring. Ty Schlobohm...

Several large drug companies – including Merck & Co., AstraZeneca, Bristol-Myers Squibb, and GlaxoSmithKline – have said that they are being investigated for bribing government officials...

Novartis Pharmaceuticals Corporation has agreed to pay $422.5 million in two separate settlements resulting from their alleged off-label drug marketing. According to the accusation, Novartis profited by...

The Supreme Court has added two cases to its docket that will examine the possible limitations of the “sate secrets” doctrine. These cases involve Navy and military contractors whose contracts have...

The House of Representatives has passed a bill that would ban corporate executives from doing business with Medicare if their companies engaged in Medicare fraud – even if they left the companies before...

While the exchanges bicker over the cost of implementing real-time market tracking systems (“Charges Bring SEC Hope for New Weapon,” Wall Street Journal, Aug. 30), on-the-ground whistleblowers remain...

In a 73-page report released today, Senator Charles Grassley (R-Iowa) has accused the Pentagon’s official watchdog of complete failure in their responsibility to audit defense contracts to prevent fraud....

Cisco and Westcon Group North America have agreed to pay $48 million to settle allegations that they violated the False Claims Act through misrepresentations made to the General Services Administration...

There’s a remarkable new trend in federal courts: Judges are refusing to rubber stamp deals federal agencies have worked out with financial industry defendants. Is this a sign of things to come? The...

Allergen, Inc., the maker of Botox Therapeutic, has agreed to plead guilty and pay $600 million, following the criminal and civil accusations that it was actively promoting Botox for “off-label” uses...